Form 4: Amphastar Pharmaceuticals CFO William J. Peters Sells Shares

William J. Peters, CFO, EVP & Treasurer of Amphastar Pharmaceuticals, sold shares of common stock on June 27, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• William J. Peters, the CFO, EVP & Treasurer of Amphastar Pharmaceuticals, sold shares of the company's common stock on June 27, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on March 14, 2024.
• A total of 2,961 shares were sold at a weighted average price of $40.8467, with individual prices ranging from $40.20 to $41.12.
• An additional 635 shares were sold at a weighted average price of $41.2946, with individual prices ranging from $41.22 to $41.36.
• Following these transactions, Peters directly owns 94,103 shares of Amphastar Pharmaceuticals common stock.
• This total includes 431 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction was pre-planned under a 10b5-1 trading plan. It doesn't necessarily reflect a positive or negative outlook on the company's future.

Industry Context

Insider sales are a common occurrence and are often viewed in the context of pre-planned trading activities, especially when executed under Rule 10b5-1 plans. It's important to consider the overall trend of insider transactions and company performance to assess the significance of this sale.

Stakeholder Impact

• The sale could have a minor negative impact on shareholder sentiment, although the pre-planned nature of the transaction mitigates this concern.

Key Dates